Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol

Immunity

Volumn 38, Issue 1, 2013, Pages 92-105

  Liu, Su Yang ^a   Aliyari, Roghiyh ^a   Chikere, Kelechi ^a   Li, Guangming ^c   Marsden, Matthew D ^a,b   Smith, Jennifer K ^d   Pernet, Olivier ^a   Guo, Haitao ^c   Nusbaum, Rebecca ^d   Zack, Jerome A ^a,b   Freiberg, Alexander N ^d   Su, Lishan ^c   Lee, Benhur ^a,b   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; CHOLESTEROL 25 HYDROXYLASE; INTERFERON; OXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; MOUSE; NIPAH VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T CELL DEPLETION; VIROGENESIS; VIRUS ENTRY; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL MEMBRANE; DNA VIRUSES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYCHOLESTEROLS; INTERFERONS; MEMBRANE FUSION; MICE; MICE, KNOCKOUT; RNA VIRUSES; STEROID HYDROXYLASES; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84872790828     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.11.005     Document Type: Article

References (28)

1. Bauman D.R., Bitmansour A.D., McDonald J.G., Thompson B.M., Liang G., Russell D.W. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. USA 2009, 106:16764-16769.
2. Brass A.L., Huang I.-C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
3. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
4. Cavrois M., De Noronha C., Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 2002, 20:1151-1154.
5. Degols G., Eldin P., Mechti N. ISG20, an actor of the innate immune response. Biochimie 2007, 89:831-835.
6. Gale S.E., Westover E.J., Dudley N., Krishnan K., Merlin S., Scherrer D.E., Han X., Zhai X., Brockman H.L., Brown R.E., et al. Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions. J. Biol. Chem. 2009, 284:1755-1764.
7. García M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006, 70:1032-1060.
8. Holmes R., VandeBerg J., Cox L. Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H). 3 Biotech 2011, 1:99-109.
9. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA 1999, 96:266-271.
10. Kandutsch A.A., Chen H.W., Heiniger H.J. Biological activity of some oxygenated sterols. Science 1978, 201:498-501.
11. Kielian M., Rey F.A. Virus membrane-fusion proteins: more than one way to make a hairpin. Nat. Rev. Microbiol. 2006, 4:67-76.
12. Lange Y., Ye J., Strebel F. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J. Lipid Res. 1995, 36:1092-1097.
13. Liu S.-Y., Sanchez D.J., Aliyari R., Lu S., Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. Proc. Natl. Acad. Sci. USA 2012, 109:4239-4244.
14. Moog C., Aubertin A.M., Kirn A., Luu B. Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro. Antivir. Chem. Chemother. 1998, 9:491-496.
15. Negrete O.A., Wolf M.C., Aguilar H.C., Enterlein S., Wang W., Mühlberger E., Su S.V., Bertolotti-Ciarlet A., Flick R., Lee B. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog. 2006, 2:e7.
16. Neil S.J.D., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
17. Olsen B.N., Schlesinger P.H., Ory D.S., Baker N.A. 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes. Biophys. J. 2011, 100:948-956.
18. Park K., Scott A.L. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 2010, 88:1081-1087.
19. Pécheur E.-I., Sainte-Marie J., Bienvenüe A., Hoekstra D. Lipid headgroup spacing and peptide penetration, but not peptide oligomerization, modulate peptide-induced fusion. Biochemistry 1999, 38:364-373.
20. Pezacki J.P., Sagan S.M., Tonary A.M., Rouleau Y., Bélanger S., Supekova L., Su A.I. Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chem. Biol. 2009, 9:2.
21. Teissier é., Pécheur E.-I. Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur. Biophys. J. 2007, 36:887-899.
22. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
23. Vaney M.-C., Rey F.A. Class II enveloped viruses. Cell. Microbiol. 2011, 13:1451-1459.
24. Wang F., Xia W., Liu F., Li J., Wang G., Gu J. Interferon regulator factor 1/retinoic inducible gene I (IRF1/RIG-I) axis mediates 25-hydroxycholesterol-induced interleukin-8 production in atherosclerosis. Cardiovasc. Res. 2012, 93:190-199.
25. Wolf M.C., Wang Y., Freiberg A.N., Aguilar H.C., Holbrook M.R., Lee B. A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics. Virol. J. 2009, 6:119.
26. Wolf M.C., Freiberg A.N., Zhang T., Akyol-Ataman Z., Grock A., Hong P.W., Li J., Watson N.F., Fang A.Q., Aguilar H.C., et al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proc. Natl. Acad. Sci. USA 2010, 107:3157-3162.
27. Zlokarnik G., Negulescu P.A., Knapp T.E., Mere L., Burres N., Feng L., Whitney M., Roemer K., Tsien R.Y. Quantitation of transcription and clonal selection of single living cells with β-lactamase as reporter. Science 1998, 279:84-88.
28. Zou T., Garifulin O., Berland R., Boyartchuk V.L. Listeria monocytogenes infection induces prosurvival metabolic signaling in macrophages. Infect. Immun. 2011, 79:1526-1535.